Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer
Recruiting · NCT07153458 · Observational (researchers observe without assigning treatment) · Lead sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
View the official record on ClinicalTrials.gov →What this trial is about
The study in question is an observational study that aims to identify new non-invasive biomarkers present in the serum of patients with CRC and, subsequently, to create a score capable of predicting the development of CRC. It is an observational study with 3 enrollment arms: Arm 1: Patients undergoing surgery at the U.O.C. of Surgery, with a CRC diagnosis; Arm 2: Subjects with a negative result from the endoscopic examination; Arm 3: Subjects in whom the presence of an adenoma with high-grade dysplasia is found, a condition considered pre-cancerous.
Who can take part
Inclusion criteria
- AIM 1: Patients undergoing surgery at the U.O.C. of Surgery, with a diagnosis of CRC.
- AIM 2: Subjects without colon disease.
- AIM 3: Subjects with adenoma and high-grade dysplasia.
Exclusion criteria
- Subject with any other pathology not included in the inclusion criteria.
Where it is running
1 location listed.
- Biobank Core Facility - Castellana Grotte, Italy